{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:03:24Z","timestamp":1792001004701,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["CB-2013-219932"],"award-info":[{"award-number":["CB-2013-219932"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s00262-017-1979-x","type":"journal-article","created":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T14:37:01Z","timestamp":1489415821000},"page":"765-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The PD-L1\/PD-1 pathway promotes dysfunction, but not \u201cexhaustion\u201d, in tumor-responding T cells from pleural effusions in lung cancer patients"],"prefix":"10.1007","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-3244","authenticated-orcid":false,"given":"Heriberto","family":"Prado-Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Romero-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Puerto-Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uriel","family":"Rumbo-Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,13]]},"reference":[{"key":"1979_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65:87\u2013108. doi: 10.3322\/caac.21262","journal-title":"CA Cancer J Clin"},{"key":"1979_CR2","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1158\/1078-0432.CCR-03-0239","volume":"10","author":"D Atanackovic","year":"2004","unstructured":"Atanackovic D, Block A, de Weerth A, Faltz C, Hossfeld DK, Hegewisch-Becker S (2004) Characterization of effusion-infiltrating T cells: benign versus malignant effusions. Clin Cancer Res 10:2600\u20132608. doi: 10.1158\/1078-0432.CCR-03-0239","journal-title":"Clin Cancer Res"},{"key":"1979_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.lungcan.2004.07.046","volume":"47","author":"H Prado-Garcia","year":"2005","unstructured":"Prado-Garcia H, Aguilar-Cazares D, Flores-Vergara H, Mandoki JJ, Lopez-Gonzalez JS (2005) Effector, memory and naive CD8+ T cells in peripheral blood and pleural effusion from lung adenocarcinoma patients. Lung Cancer 47:361\u2013371. doi: 10.1016\/j.lungcan.2004.07.046","journal-title":"Lung Cancer"},{"key":"1979_CR4","doi-asserted-by":"publisher","first-page":"741741","DOI":"10.1155\/2012\/741741","volume":"2012","author":"H Prado-Garcia","year":"2012","unstructured":"Prado-Garcia H, Romero-Garcia S, Aguilar-Cazares D, Meneses-Flores M, Lopez-Gonzalez JS (2012) Tumor-induced CD8+ T-cell dysfunction in lung cancer patients. Clin Dev Immunol 2012:741741. doi: 10.1155\/2012\/741741","journal-title":"Clin Dev Immunol"},{"key":"1979_CR5","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","volume":"56","author":"C Blank","year":"2007","unstructured":"Blank C, Mackensen A (2007) Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion. Cancer Immunol Immunother 56:739\u2013745. doi: 10.1007\/s00262-006-0272-1","journal-title":"Cancer Immunol Immunother"},{"key":"1979_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1093\/intimm\/dxm057","volume":"19","author":"T Okazaki","year":"2007","unstructured":"Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19:813\u2013824. doi: 10.1093\/intimm\/dxm057","journal-title":"Int Immunol"},{"key":"1979_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nri3862","volume":"15","author":"EJ Wherry","year":"2015","unstructured":"Wherry EJ, Kurachi M (2015) Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol 15:486\u2013499. doi: 10.1038\/nri3862","journal-title":"Nat Rev Immunol"},{"key":"1979_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-662-44006-3_5","volume-title":"Cancer immunology: a translational medicine context","author":"H Prado-Garcia","year":"2015","unstructured":"Prado-Garcia H, Romero-Garcia S, Lopez-Gonzalez JS (2015) The role of exhaustion in tumor-induced T cell dysfunction in cancer. In: Rezaei N (ed) Cancer immunology: a translational medicine context. Springer, Berlin, pp\u00a061\u201375"},{"key":"1979_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.lungcan.2003.09.005","volume":"43","author":"JS Lopez-Gonzalez","year":"2004","unstructured":"Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J, Mandoki JJ (2004) Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer 43:275\u2013283. doi: 10.1016\/j.lungcan.2003.09.005","journal-title":"Lung Cancer"},{"key":"1979_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00262-007-0372-6","volume":"57","author":"H Prado-Garcia","year":"2008","unstructured":"Prado-Garcia H, Aguilar-Cazares D, Meneses-Flores M, Morales-Fuentes J, Lopez-Gonzalez JS (2008) Lung carcinomas do not induce T-cell apoptosis via the Fas\/Fas ligand pathway but down-regulate CD3 epsilon expression. Cancer Immunol Immunother 57:325\u2013336. doi: 10.1007\/s00262-007-0372-6","journal-title":"Cancer Immunol Immunother"},{"key":"1979_CR11","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1745-7254.2005.00086.x","volume":"26","author":"XH He","year":"2005","unstructured":"He XH, Xu LH, Liu Y (2005) Identification of a novel splice variant of human PD-L1 mRNA encoding an isoform-lacking Igv-like domain. Acta Pharmacol Sin 26:462\u2013468. doi: 10.1111\/j.1745-7254.2005.00086.x","journal-title":"Acta Pharmacol Sin"},{"key":"1979_CR12","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/ten.TEC.2012.0150","volume":"19","author":"LY Chan","year":"2013","unstructured":"Chan LY, Yim EK, Choo AB (2013) Normalized median fluorescence: an alternative flow cytometry analysis method for tracking human embryonic stem cell states during differentiation. Tissue Eng Part C Methods 19:156\u2013165. doi: 10.1089\/ten.TEC.2012.0150","journal-title":"Tissue Eng Part C Methods"},{"key":"1979_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1399-0039.2006.00701.x","volume":"69","author":"J Sun","year":"2007","unstructured":"Sun J, Xu K, Wu C et al (2007) PD-L1 expression analysis in gastric carcinoma tissue and blocking of tumor-associated PD-L1 signaling by two functional monoclonal antibodies. Tissue Antigens 69:19\u201327. doi: 10.1111\/j.1399-0039.2006.00701.x","journal-title":"Tissue Antigens"},{"key":"1979_CR14","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00262-011-1165-5","volume":"61","author":"H Prado-Garcia","year":"2012","unstructured":"Prado-Garcia H, Romero-Garcia S, Morales-Fuentes J, Aguilar-Cazares D, Lopez-Gonzalez JS (2012) Activation-induced cell death of memory CD8+ T cells from pleural effusion of lung cancer patients is mediated by the type II Fas-induced apoptotic pathway. Cancer Immunol Immunother 61:1065\u20131080. doi: 10.1007\/s00262-011-1165-5","journal-title":"Cancer Immunol Immunother"},{"key":"1979_CR15","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1172\/jci43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan RH, Golden-Mason L, Nishimura MI, McMahon BJ, Kemper M, Allen TM, Gretch DR, Rosen HR (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120:4546\u20134557. doi: 10.1172\/jci43127","journal-title":"J Clin Invest"},{"key":"1979_CR16","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1084\/jem.20131916","volume":"211","author":"MZ Noman","year":"2014","unstructured":"Noman MZ, Desantis G, Janji B, Hasmim M, Karray S, Dessen P, Bronte V, Chouaib S (2014) PD-L1 is a novel direct target of HIF-1alpha, and its blockade under hypoxia enhanced MDSC-mediated T cell activation. J Exp Med 211:781\u2013790. doi: 10.1084\/jem.20131916","journal-title":"J Exp Med"},{"key":"1979_CR17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3389\/fimmu.2016.00355","volume":"7","author":"AM White","year":"2016","unstructured":"White AM, Wraith DC (2016) Tr1-like T cells\u2014an enigmatic regulatory T cell lineage. Front Immunol 7:355. doi: 10.3389\/fimmu.2016.00355","journal-title":"Front Immunol"},{"key":"1979_CR18","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1086\/340637","volume":"185","author":"F Kern","year":"2002","unstructured":"Kern F, Bunde T, Faulhaber N et al (2002) Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 185:1709\u20131716. doi: 10.1086\/340637","journal-title":"J Infect Dis"},{"key":"1979_CR19","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/cyto.a.20643","volume":"73","author":"V Appay","year":"2008","unstructured":"Appay V, van Lier RA, Sallusto F, Roederer M (2008) Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A 73:975\u2013983. doi: 10.1002\/cyto.a.20643","journal-title":"Cytometry A"},{"key":"1979_CR20","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ et al (2012) Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N Engl J Med 366:2455\u20132465. doi: 10.1056\/NEJMoa1200694","journal-title":"N Engl J Med"},{"key":"1979_CR21","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","volume":"375","author":"M Reck","year":"2016","unstructured":"Reck M, Rodriguez-Abreu D, Robinson AG et al (2016) Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N Engl J Med 375:1823\u20131833. doi: 10.1056\/NEJMoa1606774","journal-title":"N Engl J Med"},{"key":"1979_CR22","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1158\/0008-5472.can-13-0992","volume":"74","author":"IB Barsoum","year":"2014","unstructured":"Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74:665\u2013674. doi: 10.1158\/0008-5472.can-13-0992","journal-title":"Cancer Res"},{"key":"1979_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1038\/bjc.2015.101","volume":"112","author":"K Abiko","year":"2015","unstructured":"Abiko K, Matsumura N, Hamanishi J et al (2015) IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer. Br J Cancer 112:1501\u20131509. doi: 10.1038\/bjc.2015.101","journal-title":"Br J Cancer"},{"key":"1979_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3389\/fimmu.2016.00032","volume":"7","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Ertl HC (2016) Starved and Asphyxiated: how can CD8+ T Cells within a tumor microenvironment prevent tumor progression. Front Immunol 7:32. doi: 10.3389\/fimmu.2016.00032 (eCollection 2016)","journal-title":"Front Immunol"},{"key":"1979_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1165\/rcmb.2008-0139OC","volume":"42","author":"J Roman","year":"2010","unstructured":"Roman J, Rangasamy T, Guo J et al (2010) T-cell activation under hypoxic conditions enhances IFN-gamma secretion. Am J Respir Cell Mol Biol 42:123\u2013128. doi: 10.1165\/rcmb.2008-0139OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"1979_CR26","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1158\/2326-6066.cir-14-0226","volume":"3","author":"A Zippelius","year":"2015","unstructured":"Zippelius A, Schreiner J, Herzig P, Muller P (2015) Induced PD-L1 expression mediates acquired resistance to agonistic anti-CD40 treatment. Cancer Immunol Res 3:236\u2013244. doi: 10.1158\/2326-6066.cir-14-0226","journal-title":"Cancer Immunol Res"},{"key":"1979_CR27","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/cmi.2010.28","volume":"7","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Huang S, Gong D, Qin Y, Shen Q (2010) Programmed death-1 upregulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. Cell Mol Immunol 7:389\u2013395. doi: 10.1038\/cmi.2010.28","journal-title":"Cell Mol Immunol"},{"key":"1979_CR28","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1158\/2326-6066.CIR-15-0097","volume":"3","author":"DS Thommen","year":"2015","unstructured":"Thommen DS, Schreiner J, Muller P et al (2015) Progression of lung cancer is associated with increased dysfunction of T cells defined by coexpression of multiple inhibitory receptors. Cancer Immunol Res 3:1344\u20131355. doi: 10.1158\/2326-6066.CIR-15-0097","journal-title":"Cancer Immunol Res"},{"key":"1979_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.tube.2013.10.007","volume":"94","author":"W Yin","year":"2014","unstructured":"Yin W, Tong ZH, Cui A, Zhang JC, Ye ZJ, Yuan ML, Zhou Q, Shi HZ (2014) PD-1\/PD-Ls pathways between CD4(+) T cells and pleural mesothelial cells in human tuberculous pleurisy. Tuberculosis (Edinb) 94:131\u2013139. doi: 10.1016\/j.tube.2013.10.007","journal-title":"Tuberculosis (Edinb)"},{"key":"1979_CR30","first-page":"1529","volume":"35","author":"H Prado-Garcia","year":"2015","unstructured":"Prado-Garcia H, Romero-Garcia S, Rumbo-Nava U, Lopez-Gonzalez JS (2015) Predominance of Th17 over regulatory T-cells in pleural effusions of patients with lung cancer implicates a proinflammatory profile. Anticancer Res 35:1529\u20131535","journal-title":"Anticancer Res"},{"key":"1979_CR31","doi-asserted-by":"publisher","first-page":"e30676","DOI":"10.1371\/journal.pone.0030676","volume":"7","author":"X Gao","year":"2012","unstructured":"Gao X, Zhu Y, Li G et al (2012) TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression. PLoS One 7:e30676. doi: 10.1371\/journal.pone.0030676","journal-title":"PLoS One"},{"key":"1979_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/blood-2006-11-056168","volume":"110","author":"M Wolfl","year":"2007","unstructured":"Wolfl M, Kuball J, Ho WY, Nguyen H, Manley TJ, Bleakley M, Greenberg PD (2007) Activation-induced expression of CD137 permits detection, isolation, and expansion of the full repertoire of CD8+ T cells responding to antigen without requiring knowledge of epitope specificities. Blood 110:201\u2013210. doi: 10.1182\/blood-2006-11-056168","journal-title":"Blood"},{"key":"1979_CR33","doi-asserted-by":"publisher","first-page":"735","DOI":"10.4161\/onci.20823","volume":"1","author":"C Haymaker","year":"2012","unstructured":"Haymaker C, Wu R, Bernatchez C, Radvanyi L (2012) PD-1 and BTLA and CD8(+) T-cell \u201cexhaustion\u201d in cancer: \u201cexercising\u201d an alternative viewpoint. Oncoimmunology 1:735\u2013738. doi: 10.4161\/onci.20823","journal-title":"Oncoimmunology"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-017-1979-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-017-1979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-017-1979-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T20:10:42Z","timestamp":1601755842000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-017-1979-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,13]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["1979"],"URL":"https:\/\/doi.org\/10.1007\/s00262-017-1979-x","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,13]]}}}